Mode
Text Size
Log in / Sign up

Proteinuria

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Proteinuria

11 trials tracked for Proteinuria: 6 in phase 3 or 4 and 2 with published results. The most-cited published study has 41 citations.

11Trials tracked
6Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 4 Phase 2 4 Other / NA 1
  1. Phase 4 Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Completed · 41 cited
  2. Phase 4 Angiotensin II Blockade for Chronic Allograft Nephropathy Completed · 29 cited
  3. Phase 3 Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression Completed
  4. Phase 3 The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease Completed
  5. Phase 3 ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial Completed
  6. Phase 3 An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) Completed
Show 5 more trials
  1. Phase 2 Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) Completed
  2. Phase 2 Belatacept Conversion in Proteinuric Kidney Transplant Recipients Completed
  3. Phase 2 Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria Completed
  4. Phase 2 N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy Completed
  5. N/A Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.